FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997230494> ?p ?o ?g. }

• W2997230494 endingPage "1104" @default.
• W2997230494 startingPage "1095" @default.
• W2997230494 abstract "Background and AimsEUS-guided microforceps biopsy sampling (MFB) and needle-based confocal laser endomicroscopy (nCLE) are emerging diagnostic tools for pancreatic cystic lesions (PCLs). There is a paucity of data regarding their performance and impact. The aim of this study was to compare diagnostic outcomes and changes in clinical management resulting from MFB and nCLE use in PCLs.MethodsThis was a single-center retrospective study of patients with PCLs who underwent combined EUS-guided FNA, MFB, and nCLE. Primary outcomes included diagnostic yield (specific PCL type) and change in clinical management for each modality compared with the current “composite standard” (CS) obtained by combining clinical, morphologic, cyst fluid cytology, and chemical analysis.ResultsForty-four cysts were studied in 44 patients. Technical success was 100% for EUS-FNA, 88.6% for MFB, and 97.7% for nCLE. Of 44 procedures, there was 1 adverse event (2.3%, an infected pseudocyst). Diagnostic yield for each individual modality was 34.1% for CS, 75.0% for MFB (P < .05 vs CS), and 84.1% for nCLE (P < .05 vs CS). Diagnostic yield for combined tests was 79.5% for CS/MFB, 88.6% for CS/nCLE, and 93.2% for CS/MFB/nCLE (P = not significant). Compared with the CS, the use of MFB, nCLE, and their combination led to overall change in clinical management in 38.6%, 43.2%, and 52.3% of cases, respectively. MFB and nCLE led to an overall increase in discontinuation of surveillance (MFB, 34.1% [P < .05]; nCLE, 31.8% [P < .05]), led by a reduction in the indication for follow-up radiologic or endoscopic studies (MFB, 34.1% [P < .05]; nCLE, 38.6% [P < .05]). Based on MFB and nCLE, 2 of 28 (7.1%) and 3 of 28 (10.7%) patients who would have undergone further surveillance were referred for surgery.ConclusionsIn the evaluation of PCLs, the use of combined EUS-guided FNA, MFB, and nCLE is safe. MFB and nCLE led to significant improvements in specific PCL diagnosis, which in turn has major impacts in clinical management. EUS-guided microforceps biopsy sampling (MFB) and needle-based confocal laser endomicroscopy (nCLE) are emerging diagnostic tools for pancreatic cystic lesions (PCLs). There is a paucity of data regarding their performance and impact. The aim of this study was to compare diagnostic outcomes and changes in clinical management resulting from MFB and nCLE use in PCLs. This was a single-center retrospective study of patients with PCLs who underwent combined EUS-guided FNA, MFB, and nCLE. Primary outcomes included diagnostic yield (specific PCL type) and change in clinical management for each modality compared with the current “composite standard” (CS) obtained by combining clinical, morphologic, cyst fluid cytology, and chemical analysis. Forty-four cysts were studied in 44 patients. Technical success was 100% for EUS-FNA, 88.6% for MFB, and 97.7% for nCLE. Of 44 procedures, there was 1 adverse event (2.3%, an infected pseudocyst). Diagnostic yield for each individual modality was 34.1% for CS, 75.0% for MFB (P < .05 vs CS), and 84.1% for nCLE (P < .05 vs CS). Diagnostic yield for combined tests was 79.5% for CS/MFB, 88.6% for CS/nCLE, and 93.2% for CS/MFB/nCLE (P = not significant). Compared with the CS, the use of MFB, nCLE, and their combination led to overall change in clinical management in 38.6%, 43.2%, and 52.3% of cases, respectively. MFB and nCLE led to an overall increase in discontinuation of surveillance (MFB, 34.1% [P < .05]; nCLE, 31.8% [P < .05]), led by a reduction in the indication for follow-up radiologic or endoscopic studies (MFB, 34.1% [P < .05]; nCLE, 38.6% [P < .05]). Based on MFB and nCLE, 2 of 28 (7.1%) and 3 of 28 (10.7%) patients who would have undergone further surveillance were referred for surgery. In the evaluation of PCLs, the use of combined EUS-guided FNA, MFB, and nCLE is safe. MFB and nCLE led to significant improvements in specific PCL diagnosis, which in turn has major impacts in clinical management." @default.
• W2997230494 created "2020-01-10" @default.
• W2997230494 creator A5011244549 @default.
• W2997230494 creator A5046175230 @default.
• W2997230494 creator A5050126574 @default.
• W2997230494 creator A5053983618 @default.
• W2997230494 creator A5072538581 @default.
• W2997230494 creator A5079905994 @default.
• W2997230494 creator A5083875850 @default.
• W2997230494 date "2020-05-01" @default.
• W2997230494 modified "2023-09-24" @default.
• W2997230494 title "Impact of EUS-guided microforceps biopsy sampling and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions" @default.
• W2997230494 cites W1878579293 @default.
• W2997230494 cites W1998011852 @default.
• W2997230494 cites W2024951572 @default.
• W2997230494 cites W2093467790 @default.
• W2997230494 cites W2111783470 @default.
• W2997230494 cites W2120132690 @default.
• W2997230494 cites W2128494449 @default.
• W2997230494 cites W2133448114 @default.
• W2997230494 cites W2593137514 @default.
• W2997230494 cites W2612605981 @default.
• W2997230494 cites W2736069212 @default.
• W2997230494 cites W2789917807 @default.
• W2997230494 cites W2896946021 @default.
• W2997230494 cites W2903071224 @default.
• W2997230494 doi "https://doi.org/10.1016/j.gie.2019.12.022" @default.
• W2997230494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31881204" @default.
• W2997230494 hasPublicationYear "2020" @default.
• W2997230494 type Work @default.
• W2997230494 sameAs 2997230494 @default.
• W2997230494 citedByCount "30" @default.
• W2997230494 countsByYear W29972304942020 @default.
• W2997230494 countsByYear W29972304942021 @default.
• W2997230494 countsByYear W29972304942022 @default.
• W2997230494 countsByYear W29972304942023 @default.
• W2997230494 crossrefType "journal-article" @default.
• W2997230494 hasAuthorship W2997230494A5011244549 @default.
• W2997230494 hasAuthorship W2997230494A5046175230 @default.
• W2997230494 hasAuthorship W2997230494A5050126574 @default.
• W2997230494 hasAuthorship W2997230494A5053983618 @default.
• W2997230494 hasAuthorship W2997230494A5072538581 @default.
• W2997230494 hasAuthorship W2997230494A5079905994 @default.
• W2997230494 hasAuthorship W2997230494A5083875850 @default.
• W2997230494 hasBestOaLocation W29972304941 @default.
• W2997230494 hasConcept C126838900 @default.
• W2997230494 hasConcept C142724271 @default.
• W2997230494 hasConcept C18823058 @default.
• W2997230494 hasConcept C2775934546 @default.
• W2997230494 hasConcept C2780597408 @default.
• W2997230494 hasConcept C2989005 @default.
• W2997230494 hasConcept C71924100 @default.
• W2997230494 hasConceptScore W2997230494C126838900 @default.
• W2997230494 hasConceptScore W2997230494C142724271 @default.
• W2997230494 hasConceptScore W2997230494C18823058 @default.
• W2997230494 hasConceptScore W2997230494C2775934546 @default.
• W2997230494 hasConceptScore W2997230494C2780597408 @default.
• W2997230494 hasConceptScore W2997230494C2989005 @default.
• W2997230494 hasConceptScore W2997230494C71924100 @default.
• W2997230494 hasIssue "5" @default.
• W2997230494 hasLocation W29972304941 @default.
• W2997230494 hasOpenAccess W2997230494 @default.
• W2997230494 hasPrimaryLocation W29972304941 @default.
• W2997230494 hasRelatedWork W1511885230 @default.
• W2997230494 hasRelatedWork W1601878435 @default.
• W2997230494 hasRelatedWork W1974980412 @default.
• W2997230494 hasRelatedWork W1985283144 @default.
• W2997230494 hasRelatedWork W2028147867 @default.
• W2997230494 hasRelatedWork W2125960178 @default.
• W2997230494 hasRelatedWork W2410255654 @default.
• W2997230494 hasRelatedWork W2427158308 @default.
• W2997230494 hasRelatedWork W2792053644 @default.
• W2997230494 hasRelatedWork W3202562093 @default.
• W2997230494 hasVolume "91" @default.
• W2997230494 isParatext "false" @default.
• W2997230494 isRetracted "false" @default.
• W2997230494 magId "2997230494" @default.
• W2997230494 workType "article" @default.